Abt Associates: Bold thinkers driving real-world impact
High pharmaceutical prices and a high prevalence of fake, substandard, and expired drugs have challenged Nigerian health facilities’ efforts to maintain reliable drug supplies. This in turn has complicated efforts to improve the health of many Nigerians.
Millions more Nigerians are getting affordable, quality pharmaceuticals through the assistance and training provided by an Abt-led project.
Drug revolving funds (DRFs) are a way to guarantee good-quality drugs direct from manufacturers at affordable costs. After an initial capital investment, drug supplies are replenished with the money collected from the drug sales. DRFs eliminate intermediaries who often markup drug prices excessively.
Abt Associates is a mission-driven, global leader in research, evaluation and program implementation in the fields of health, social and environmental policy, and international development. Known for its rigorous approach to solving complex challenges, Abt Associates is regularly ranked as one of the top 20 global research firms and one of the top 40 international development innovators. The company has multiple offices in the U.S. and program offices in more than 40 countries.